close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

AARP Welcomes Senate Passage of Rx Importation, but Promises to Fight Unnecessary Importation Roadblocks

Looks to House to clear the way for safe, legal importation of lower-priced prescription drugs

WASHINGTON, May 07, 2007 /PRNewswire-USNewswire/ -- The U.S. Senate today approved an amendment that would allow for the safe and legal importation of lower-priced prescription drugs from abroad.

The amendment would legalize the importation of FDA-approved medications from certain countries beginning with Canada, impose strict safety standards to prevent drug counterfeiting, and include important provisions to prevent potential trade obstructions. The amendment was introduced by Senators Byron Dorgan (D-ND) and Olympia Snowe (R-ME).

"Americans pay among the highest prices for brand name drugs in the world. Today the U.S. Senate told the pharmaceutical industry that we will no longer accept this unfair arrangement where Americans subsidize lower drug prices for the rest of the world," said AARP CEO Bill Novelli.

Along with the amendment passed today, the Senate also passed an unnecessary road block intended to prevent the safe and legal importation of prescription drugs. In a move designed to block the Dorgan-Snowe measure, language was added prohibiting importation of prescription drugs unless the Secretary of Health and Human Services can certify that it is safe to do so. Despite the fact that safety provisions are already built into the bill, this provision is designed to give unnecessary discretion to the Secretary to block importation.

"Pharmaceutical companies already manufacture prescription drugs all over the world and safely bring them into the U.S.," continued Novelli. "In 2004, when faced with a flu vaccine shortage, the FDA was able to arrange the importation of flu vaccine from the European Union in a matter of weeks. Further, there are no similar certification provisions in existence for other products routinely imported into this country. This poison-pill 'certification' amendment is intended to do one thing: preserve the status quo and prevent Americans from having a safe and legal process for accessing lower-priced prescription drugs.

"A vote for 'certification' is a vote against safe and legal importation. As part of our ongoing accountability campaign, AARP will be recording Senators' votes on both the Dorgan-Snowe and the certification amendments. We will inform our members about these votes, and how their Senators voted," Novelli concluded.

The importation of prescription drugs is not the sole solution to soaring drug prices in the U.S. However, AARP believes that a system providing for the safe and legal importation of prescription drugs can serve to put downward pressure on drug prices and will permit consumers to realize savings on the cost of their prescription drugs.

The amendments were made to the Prescription Drug User Fee Act of 2007 (S. 1082). That bill is still being debated in the Senate and is expected to be voted on in the days to come.

AARP is a nonprofit, nonpartisan membership organization that helps people 50+ have independence, choice and control in ways that are beneficial and affordable to them and society as a whole. We produce AARP The Magazine, published bimonthly; AARP Bulletin, our monthly newspaper; AARP Segunda Juventud, our bimonthly magazine in Spanish and English; NRTA Live & Learn, our quarterly newsletter for 50+ educators; and our website, AARP.org. AARP Foundation is an affiliated charity that provides security, protection, and empowerment to older persons in need with support from thousands of volunteers, donors, and sponsors. We have staffed offices in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.

CONTACT: Drew Nannis or Nancy Wood, both of AARP, +1-202-434-2560

Web site: http://www.aarp.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...